Autopsy report · NCT00721422
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
Cause of deathNo reason given
“Please see Detailed Description for termination reason.”
Life of this trial
- Ran for about 6 months before it stopped.
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Renal Insufficiency; Pharmacokinetics
- Interventions
- PD 0332334; PD 0332334; PD 0332334; PD 0332334
- Participants
- 16
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.